Compared with the negative control cells, CRART16-overexpressing gastric cancer cells expressed a lower level of miR-122-5p and higher FOS and VEGFD (*P < 0.05; Figure 6A, 6B). This evidence concerns the gene VEGFD and gastric cancer.